Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
CORV was delisted on the 26th of May, 2020.
30 hedge funds and large institutions have $62.8M invested in Correvio Pharma Corp. Ordinary Shares (Canada) in 2014 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 13 reducing their positions, and 2 closing their positions.
200% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 2
21% more capital invested
Capital invested by funds: $51.7M → $62.8M (+$11M)
12% more call options, than puts
Call options by funds: $210K | Put options by funds: $188K
11% more funds holding
Funds holding: 27 → 30 (+3)
54% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 13
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Westfield Capital Management
Boston,
Massachusetts
|
+$6.65M |
| 2 |
PI
Putnam Investments
Boston,
Massachusetts
|
+$2.42M |
| 3 |
PC
PointState Capital
New York
|
+$2.1M |
| 4 |
Mackenzie Financial
Toronto Ontario,
Ontario, Canada
|
+$157K |
| 5 |
CCP
Clough Capital Partners
Boston,
Massachusetts
|
+$114K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
-$2.95M |
| 2 |
FIG
Fortress Investment Group
New York
|
-$777K |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$716K |
| 4 |
TI
Turner Investments
Berwyn,
Pennsylvania
|
-$438K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$293K |
CORV Hedge Fund Activity: Q4 2014 in Review
30 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) for Q4 2014, worth a combined $62.8M — up 21% from $51.7M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new CORV positions and 2 closed out — a net gain of 4 holders — while 6 added to existing stakes and 13 trimmed.
The largest buyer was Westfield Capital Management, adding an estimated $6.65M. The largest seller was Adage Capital Partners, cutting an estimated $2.95M.
- 30 institutional investors held Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) as of Q4 2014, up from 27 in Q3 2014.
- Funds reported $62.8M of Correvio Pharma Corp. Ordinary Shares (Canada) stock for Q4 2014, up 21% quarter-over-quarter.
- 6 funds opened new Correvio Pharma Corp. Ordinary Shares (Canada) positions in Q4 2014 and 2 closed out, a net change of +4 holders.
- The largest Correvio Pharma Corp. Ordinary Shares (Canada) buyer in Q4 2014 was Westfield Capital Management, an estimated $6.65M added.
- The largest Correvio Pharma Corp. Ordinary Shares (Canada) seller in Q4 2014 was Adage Capital Partners, an estimated $2.95M sold.
Based on aggregated 13F filings for Q4 2014.